|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
EBSCO_on1085227461 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
190209s2019 xx o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d YDX
|d OCLCQ
|d UKAHL
|d N$T
|d OCLCO
|d OCLCF
|d OCLCO
|d K6U
|d OCLCQ
|
| 019 |
|
|
|a 1084501890
|a 1084678927
|a 1280543281
|a 1284936027
|
| 020 |
|
|
|a 1773618202
|
| 020 |
|
|
|a 9781773618203
|q (electronic bk.)
|
| 035 |
|
|
|a (OCoLC)1085227461
|z (OCoLC)1084501890
|z (OCoLC)1084678927
|z (OCoLC)1280543281
|z (OCoLC)1284936027
|
| 050 |
|
4 |
|a QP517.C45
|
| 082 |
0 |
4 |
|a 571.7/4
|2 23
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Selmy, Mohamed A.
|
| 245 |
1 |
0 |
|a Signal Transduction in Cancer
|
| 260 |
|
|
|a Ashland :
|b Delve Publishing,
|c 2019.
|
| 300 |
|
|
|a 1 online resource (242 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Cover; Half Title Page; Title Page; Copyright Page; About the Author; Table of Contents; List of Figures; List of Tables; List of Abbreviations; Preface; Introduction: Basics and Tracks of Cell Signaling; References; Chapter 1 Growth Factors and Tyrosine Kinase Receptors; 1.1. General Characteristics of the GF-TKR Interrelationship; 1.2. The Paradigmatic Model of the EGF (ERBB) Family; 1.3. Other Families of GFS and Growth Factor Receptors; 1.4. Tyrosine Phosphatase Receptors; Further Reading; Chapter 2 Map Kinase Pathway; 2.1. From Receptor Stimulation to RAS Activation; 2.2. Kinase Cascade
|
| 505 |
8 |
|
|a 2.3. Other Signaling Elements2.4. Map Kinase Substrates; 2.5. Oncogenic Changes; 2.6. Pharmacological Targeting; Further Reading; Chapter 3 Phosphatidylinositol 3-Kinase Pathway; 3.1. From Phosphatidylinositol 3-Kinase to AKT Proteins; 3.2. AKT Proteins and Their Substrates; 3.3. mTOR Protein and The TORC Complexes; 3.4. Oncogenic Alterations; 3.5. Pharmacological Targets; Further Reading; Chapter 4 G-Protein-Coupled Receptors; 4.1. Structure And Mechanism of Action of G-Protein-Coupled Receptors; 4.2. Second Messengers of GPCR Activation; 4.3. Oncogenic Changes And Pharmacological Targeting
|
| 505 |
8 |
|
|a Further ReadingChapter 5 TGFß Pathway; 5.1. TGFß Family Ligands; 5.2. Receptors Activation; 5.3. Signal Transduction In The TGFß Pathway; 5.4. Oncogenic Changes; 5.5. Pharmacological Targeting; Further Reading; Chapter 6 Cytokines Pathway; 6.1. Cytokines; 6.2. Cytokine Receptors and JAK Activation; 6.3. Signal Processing; 6.4. Oncogenic Changes; 6.5. Pharmacological Targeting; Further Reading; Chapter 7 Cell Cycle Control; 7.1. Cell Cycle Phases; 7.2. Effector Proteins of Cell Cycle Regulation; 7.3 Control of Cell Cycle Progression; 7.4. Oncogenic Changes In Cell Cycle Regulation
|
| 505 |
8 |
|
|a 7.5. Pharmacological TargetingFurther Reading; Chapter 8 WNT Pathway; 8.1. WNT Ligands and Their Receptors; 8.2. WNT-ß-Catenin Pathway; 8.3. 'Non-Canonical' WNT Pathways; 8.4. Oncogenic Changes; 8.5. Pharmacological Targeting; Further Reading; Chapter 9 Notch Pathway; 9.1. DSL Ligands; 9.2. Notch Receptors; 9.3. Notch Receptor Activation And Signal Transduction; 9.4. Oncogenic Changes; 9.5. Pharmacological Targeting; Further Reading; Chapter 10 Ion Channel-Coupled Receptors; 10.1. Activation Of Ligand-Gated Ion Channels; 10.2. Purinergic Receptors; 10.3. Ca2+ Signaling; Further Reading
|
| 505 |
8 |
|
|a Chapter 11 Apoptosis Process and Regulation11.1. Proteins Implicated In Apoptosis; 11.2. Intrinsic (Mitochondrial) Apoptosis Pathway; 11.3. Extrinsic (Death Receptor) Apoptosis Pathway; 11.4. Oncogenic Alterations Of Apoptosis Pathways; 11.5. Pharmacological Targets; 11.6. Dependence Receptors; Further Reading; Chapter 12 Hedgehog Pathway; 12.1. Hedgehog Ligands; 12.2. Patched Receptors and Their Activation; 12.3. HHG Signal Transmission; 12.4. Oncogenic Changes; 12.5. Pharmacological Targeting; Further Reading; Chapter 13 Integrins; 13.1. Integrins And Integrin Ligands
|
| 500 |
|
|
|a 13.2. Signaling Pathways Starting From Integrins
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Cellular signal transduction.
|
| 650 |
|
2 |
|a Signal Transduction
|
| 650 |
|
6 |
|a Transduction du signal cellulaire.
|
| 650 |
|
7 |
|a Cellular signal transduction.
|2 fast
|0 (OCoLC)fst00850288
|
| 776 |
0 |
8 |
|i Print version:
|a Selmy, Mohamed A.
|t Signal Transduction in Cancer.
|d Ashland : Delve Publishing, ©2019
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2014050
|z Texto completo
|
| 938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n BDZ0044472722
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL5655658
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 2014050
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 16023445
|
| 994 |
|
|
|a 92
|b IZTAP
|
